Marker Assisted Selective ThErapy in Rare Cancers: Knowledge Database Establishing registrY Asia

Clinical trial NCT05217407 · RECRUITING

Trial details

NCT number: NCT05217407
Sponsor: National Cancer Center, Japan
Status: RECRUITING
Study type: OBSERVATIONAL

Rare Malignant Neoplasm

Start date: 2021-11-30
Primary completion: 2027-03-31
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.